Semler Scientific (SMLR) shares closed at $32.06, well below the $86.30 implied value from its acquisition by Strive (ASST). The all-stock deal offers an exchange ratio of 21.05 ASST shares per SMLR share, presenting an arbitrage opportunity. Benchmark analyst Mark Palmer maintained a buy rating on SMLR, adjusting the price target to $86 from $101. The acquisition will significantly boost Strive's Bitcoin holdings, combining its 5,886 BTC with Semler's 5,021 BTC, positioning it as the 12th largest public company in terms of BTC assets. Strive also gains control of Semler's diagnostics business, with plans to monetize or spin it off. The merger's completion is contingent on S-4 registration and shareholder approval, with potential risks from fluctuations in ASST or BTC prices.